Velagliflozin

Velagliflozin
Clinical data
Trade names	Senvelgo
License data	US DailyMed: Velagliflozin;
Routes of; administration	By mouth
ATCvet code	QA10BK90 (WHO) ;
Legal status
Legal status	US: ℞-only;
Identifiers
	IUPAC name 2-[(4-cyclopropylphenyl)methyl]-4-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzonitrile;
CAS Number	946525-65-1;
PubChem CID	24862817;
ChemSpider	58827717;
UNII	FV2YU8SL0P; EQE2P2T77I;
Chemical and physical data
Formula	C23H25NO5
Molar mass	395.455 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CC1C2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C#N;
	InChI InChI=1S/C23H25NO5/c24-11-17-8-7-16(23-22(28)21(27)20(26)19(12-25)29-23)10-18(17)9-13-1-3-14(4-2-13)15-5-6-15/h1-4,7-8,10,15,19-23,25-28H,5-6,9,12H2/t19-,20-,21+,22-,23+/m1/s1; Key:SENUNDCNOYAWGN-ZQGJOIPISA-N; Key:UWKBFNWQMSGEPG-ZHNCTCHCSA-N;

Velagliflozin, sold under the brand name Senvelgo, is an antidiabetic medication used for the treatment of cats.^[1]^[2] Velagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.^[3] It is taken by mouth.^[1]

Medical uses

Velagliflozin is indicated to improve glycemic control in otherwise healthy cats with diabetes not previously treated with insulin.^[1]^[2]^[3]